Please login to the form below

Not currently logged in
Email:
Password:

Dr Reddy's makes senior changes as US generics head exits

UmangVohra will be replaced by Alok Sonig

Dr Reddy's Umang VohraDr Reddy's has appointed Alok Sonig to be its new head of North America generics to take over from Umang Vohra (pictured).

Vohra is leaving the Indian generics-focused company after nearly three years as its executive VP and head North America Generics.

In total he spent 13 years with the firm, which he joined in 2002 from Pepsico-India, where he was financial planning manager.

Vohra's replacement at Dr Reddy's is the company's head of India generics Alok Sonig who, prior to joining the firm, served at Bristol-Myers Squibb, where he spent three years as managing director of BMS India.

To fill Sonig's vacant role Dr Reddy's has handed MV Ramana, currently executive vice president - emerging markets, additional responsibilities with a move to executive vice president and head branded markets (India and emerging countries).

1st September 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics